Evaluation of systemic inflammatory biomarkers associated with high-density lipoprotein in keratoconus patients: a

Burçin Çakır1, Muhammed Muaz Osmanoğlu2, Büşra Güner Sönmezoğlu3

  • 1Department of Ophthalmology, Sakarya Training and Research Hospital, Sakarya, Turkey. burcincakir@sakarya.edu.tr.

BMC Ophthalmology
|December 24, 2025
PubMed

Insights

Platelet to HDL ratio (PHR) is elevated in keratoconus (KC) patients. This study found no correlation between systemic inflammatory markers and corneal topography in KC.

Area of Science:

  • Ophthalmology
  • Immunology
  • Biochemistry

Background:

  • Keratoconus (KC) is a progressive corneal ectasia.
  • Systemic inflammation may play a role in KC pathogenesis.
  • HDL-associated inflammatory markers require further investigation in KC.

Purpose of the Study:

  • To evaluate systemic inflammatory markers, including monocyte to HDL ratio (MHR), neutrophil to HDL ratio (NHR), lymphocyte to HDL ratio (LHR), neutrophil to lymphocyte ratio (NLR), and platelet to HDL ratio (PHR), in KC patients.
  • To investigate correlations between these markers and corneal topographic parameters.

Main Methods:

  • Retrospective analysis of peripheral blood samples from 103 KC patients and 99 controls.
  • Calculation of mean MHR, NHR, LHR, NLR, and PHR.
  • Evaluation of corneal topography markers and their correlation with systemic inflammatory markers.

Main Results:

  • The mean platelet to HDL ratio (PHR) was significantly higher in the KC group compared to controls (p=0.004).
  • An optimal PHR cut-off value of 4807 was identified for KC, with 74.8% sensitivity and 45.5% specificity.
  • No significant correlations were found between corneal topography parameters and systemic inflammatory markers.

Conclusions:

  • Mean PHR is elevated in keratoconus patients.
  • No correlation exists between HDL-associated systemic inflammatory markers and corneal topography in KC.
  • This study is the first to explore HDL-associated systemic inflammatory markers in keratoconus.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409